Identification of full-length circular RNAs linked with therapy resistance of pediatric cancers

Bessière, Chloé; Babin, Loélia; Andraos, Elissa; Riepl, Johannes Markus; Szymansky, Annabell; Lodrini, Marco; Deubzer, Hedwig E.; Eggert, Angelika; Quivoron, Cyril; Rigaud, Charlotte; Vérgé, Véronique; Pyronnet, Stéphane; Lamant, Laurence; Meggetto, Fabienne; Gaspin, Christine; Fuchs, Steffen

Identification of full-length circular RNAs linked with therapy resistance of pediatric cancers

Tools

Preview	PDF (Preprint) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader 1MB
	Other (Supplementary Material) 3MB

Item Type:	Preprint
Title:	Identification of full-length circular RNAs linked with therapy resistance of pediatric cancers
Creators Name:	Bessière, Chloé, Babin, Loélia, Andraos, Elissa, Riepl, Johannes Markus, Szymansky, Annabell, Lodrini, Marco, Deubzer, Hedwig E., Eggert, Angelika, Quivoron, Cyril, Rigaud, Charlotte, Vérgé, Véronique, Pyronnet, Stéphane, Lamant, Laurence, Meggetto, Fabienne, Gaspin, Christine and Fuchs, Steffen
Abstract:	Resistance to cancer treatment remains the leading cause of cancer-related deaths. In tumors with low mutational burden such as pediatric cancers, alternative transcripts, including circular RNAs (circRNAs), have been identified as involved in treatment resistance. However, their isoforms are often missed by commonly used short-read sequencing. Here, we employ long-read sequencing to identify full-length circRNA isoforms associated with resistance in ALK-driven pediatric cancers. Using cell models and a cohort of ALK-translocated anaplastic large-cell lymphoma (ALK+ ALCL) patients, two circRNAs were detected as specifically upregulated in resistant cases and associated with worse disease outcomes. Similar findings were observed in the pediatric cancer neuroblastoma. These circRNAs were also more abundant in liquid biopsies from ALKi-resistant ALK+ ALCL and neuroblastoma patients. This demonstrates that long-read sequencing allows for uncovering disease-relevant circRNA isoforms that could serve as biomarkers for resistance detection in a clinical setting.
Keywords:	ALK, Non Coding RNA, Lymphoma, Neuroblastoma, CircRNA, Pediatric Oncology, Nanopore Sequencing
Source:	medRxiv
Publisher:	Cold Spring Harbor Laboratory Press
Article Number:	2025.11.28.25340833
Date:	4 December 2025
Additional Information:	Accession "GSE260564" is currently private and is scheduled to be released on Feb 28, 2028. Accession "GSE266457" is currently private and is scheduled to be released on Apr 30, 2028.
Official Publication:	https://doi.org/10.64898/2025.11.28.25340833
Related to:	URL URL Type https://ftp.ensembl.org/pub/release-109/fasta/homo_sapiens/dna/Homo_sapiens.GRCh38.dna.alt.fa.gz External Dataset https://www.gencodegenes.org/human/release_41.html External Dataset https://ega-archive.org/studies/EGAS00001004022 External Dataset https://ega-archive.org/studies/EGAS00001005604 External Dataset https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE260564 External Dataset https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE266457 External Dataset https://github.com/Steffen-Fuchs/Nanopore_ALCL_circRNA Software

Repository Staff Only: item control page

Download Statistics

Downloads

Downloads per month over past year